FDA Inspection 983869 — Kaiser Permanente Center for Reproductive Health
The FDA completed an inspection of Kaiser Permanente Center for Reproductive Health on August 17, 2016 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 17, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fremont, CA (United States)